Point of Care Molecular Diagnostics (Assays, Kits, Analyzers, Software) Market - Global Forecast to 2023 - ResearchAndMarkets.com

DUBLIN--()--The "Point of Care Molecular Diagnostics Market by Product & Service (Assays, Kits, Analyzers, Software), Application (Respiratory Disease, Hospital Acquired Infection), Technology, End User (Physician Office, ICUS) - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.

The global point of care (POC) molecular diagnostics market is expected to reach USD 1440.2 million by 2023 from USD 725.5 million in 2018, at a CAGR of 14.7%

Growth in the POC molecular diagnostics market is driven by the increasing prevalence of infectious diseases, rising focus on decentralized diagnostics, and the growing demand for CLIA-waived molecular POC tests. However, inadequate reimbursement and stringent regulatory policies are likely to restrain the growth of this market during the forecast period.

Based on technology, the POC molecular diagnostics market is segmented into RT-PCR, INAAT, and other technologies. The INAAT segment is expected to grow at highest CAGR during the forecasted period. The increasing popularity of INAAT for infectious diseases diagnosis is expected to drive this market in the coming years.

While North America is expected to account for the largest share of the global POC molecular diagnostics market, Asia Pacific is projected to grow at the highest CAGR during the study period. The key factors influencing the growth of this market include growing initiatives by market players, rising demand for influenza A/B tests, decentralized healthcare delivery systems, and increasing patient population base in this region.

The key players in the global POC molecular diagnostics market are Roche Diagnostics (Switzerland), Abbott Laboratories (US), Danaher (US), Biomerieux (France), and Meridian Biosciences (US)

Key Topics Covered:

  1. Introduction
  2. Research Methodology
  3. Executive Summary
  4. Premium Insights
  5. Market Overview
  6. Point-of-Care (POC) Molecular Diagnostics Market, By Application
  7. Point-of-Care Molecular Diagnostics Market, By Technology
  8. Point-of-Care (POC) Molecular Diagnostics Market, By Product & Service
  9. Point-of-Care Molecular Diagnostics Market, By End User
  10. Point-of-Care Molecular Diagnostics Market, By Region
  11. Competitive Landscape
  12. Company Profiles
  • Abbott Laboratories
  • Danaher Corporation
  • Biomrieux Sa
  • Roche Diagnostics
  • Quidel
  • Meridian Bioscience
  • Mesa Biotech
  • Genepoc
  • DxNA
  • Atlas Genetics
  • Spartan Bioscience
  • Biocartis

For more information about this report, visit https://www.researchandmarkets.com/research/5m2kxk/point_of_care?w=4.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Point-of-Care Diagnostics, Molecular Diagnostics

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Point-of-Care Diagnostics, Molecular Diagnostics